Innovent Highlights Obesity Pipeline at ADA 2026
SAN FRANCISCO and SUZHOU, China, May 12, 2026 Innovent Biologics announced that it will present multiple clinical and preclinical...
Obesity
Advertisement
Novo Nordisk Reports 28% Weight Loss With Higher-Dose Wegovy
Bagsværd, Denmark, May 12, 2026 Novo Nordisk presented new analyses from its pivotal STEP UP clinical trial at the...
Ascletis Advances ASC30 Phase II Trial in Diabetes
Hong Kong | April 27, 2026 Ascletis Pharma Inc. has announced the successful completion of enrollment in its U.S....
Lilly Foundayo Shows Strong Phase 3 Diabetes Results
INDIANAPOLIS, April 16, 2026 Eli Lilly and Company announced positive results from its ACHIEVE-4 Phase 3 clinical trial, demonstrating...
Ambrosia Biosciences Raises $100M for GLP-1 Pipeline
BOULDER, Colo., USA — March 31, 2026 Ambrosia Biosciences Inc. has announced the successful completion of a $100 million...
Advertisements
Sun Pharma Launches Semaglutide in India Market
MUMBAI, INDIA, March 21, 2026 Sun Pharmaceutical Industries Limited has announced the launch of its semaglutide injection under the...
GLP-1 Therapy Linked to Reduced Asthma Exacerbations
MILWAUKEE, Feb. 15, 2026 — New research presented by the American Academy of Allergy, Asthma & Immunology (AAAAI) reveals...
Mazdutide Shows Strong Weight-Loss Impact in Phase 1b Trial
BEIJING, December 2025 — New Phase 1b clinical data show that mazdutide, an investigational metabolic therapy, delivered significant weight-loss...
Pfizer Finalizes Metsera Acquisition to Expand Obesity Pipeline
NEW YORK, NY — November 14, 2025 — Pfizer announced it has completed its acquisition of Metsera, Inc., strengthening...
Rhythm Pharmaceuticals Presents Four New Datasets at ObesityWeek® 2025
Boston, November 10, 2025 — Rhythm Pharmaceuticals, Inc. has announced the presentation of four pivotal datasets at ObesityWeek® 2025,...
Advertisement
